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1. Quality control 
Participants were excluded for the following reasons from visual inspection of the 
images: failure of full cortical coverage during the DWI scan and/or having a poor-
quality registration from DWI image to T1w image, and failing FreeSurfer surface 
segmentation. After quality control, 217 out of 242 MDD patients, and 208 out of 231 
HC were included in the discovery cohort. In the replication cohort, 42 out of 51 MDD 
patients and 35 out of 43 HC remained. The detailed information was shown in Table 
S1. To check differences in motion and image quality between patients with MDD and 
HC, we calculated the Euler number for each T1w image. This approach was proposed 
by Rosen et al.1 as a way to quantitatively assess image quality2, 3. Using a two-sided 
two-sample t-test, we found no significant differences in the Euler number between 
the two groups in discovery (t(423) = 0.70, p = 0.48) and replication (t(75) = 1.27, p = 0.21) 
cohorts (Figure S1).  
 




Discovery cohort Replication cohort 
MDD 
(n = 217) 
HC 
(n = 208) 
p-values MDD 
(n = 42) 
HC 
(n = 35) 
p-values 
Demographic characteristic 
Age at scan, years 38.71 (11.95) 40.11 (15.52) 0.49a 39.02 (11.86) 34.03 (12.00) 0.07a 
Female 143 (66%) 136 (65%) 0.91b 30 (71%) 26 (74%) 0.78b 
Education, years 11.93 (3.52) 12.92 (3.80) 0.0009a 9.36 (4.59) 13.66 (3.94) 4.1E-05c 
Clinical characteristic  
Duration, months 48.05 (65.86) NA NA 77.45 (94.42) NA NA 
HAMD score 21.60 (5.05) NA NA 25.14 (5.23) NA NA 
HAMA score 23.69 (8.32) NA NA 22.69 (7.05) NA NA 
Medication, yes (n = 209) 
102 (47%) 
NA NA 39 (93%) NA NA 
Note: Data are presented as either n (%) or means (standard deviations). The cohort size was 
obtained after the image data quality control.  
Abbreviations: HC, healthy controls; HAMD, 17-item Hamilton Depression Scale; HAMA, Hamilton 
Anxiety Scale; NA, not available. 
aMann-Whitney U-test (two-sided). bChi-square test. cTwo-sample t-test (two-sided). 
 




Figure S1. Euler number comparisons between MDD and HC, for both discovery and 
replication cohorts. Using a two-sample t-test, we found no significant differences in 
the Euler number between the two groups in discovery (MDD: n = 217; HC: n = 208; 
two-sample t-test: t(423) = 0.70, p = 0.48) and replication (MDD: n = 42; HC: n = 35; two-
sample t-test: t(75) = 1.27, p = 0.21) cohorts. Boxplots show the lower quartile (25th 
percentile), median, and upper quartile (75th percentile), respectively. The upper and 
lower whiskers denote the minimum and maximum, respectively.  
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2. Replicable morphometric similarity patterns in HC 
Figure S2 showed the relationship of MS pattern in HC between the current discovery 
cohort and Morgan et al. study (published online)2. These two MSN patterns were 
highly consistent (Pearson’s r(306) = 0.91, pspin < 0.0001), with high positive 
morphometric similarity in frontal and temporal cortical areas and high negative 
morphometric similarity in occipital, somatosensory, and motor cortices, suggesting 
the robust and replicable regional MSN distribution.  
 
 
Figure S2. Replicable MS pattern in HC. a Regional MS averaged over HC in Morgan 
et al. study3. b Mean regional MS in HC in discovery cohorts of the present study. c 
Pearson’s correlation analysis of regional MS between the two studies across regions 
(Pearson’s r(306) = 0.91, pspin = 0.00). p value was determined based on a one-sided test. 
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3. Threshold selection in construction of MSN of HC 
Threshold selection is a complex issue in network construction3. To validate the effects 
of thresholding on the MSNs, we calculated strength at a range of connection densities 
(10%‒90% in 10% increments) generated by thresholding the MSNs. At all connection 
densities, the MSNs in HC demonstrated similar distributions of nodal strength with 
mean HC MSN based on non-thresholded networks; Figure 2a (Pearson’s r values 
range from 0.406 to 0.998, all pspin < 0.0001, FDR-corrected; Figure S3).  
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Figure S3. Replicable MSNs across connection densities in HC. Left panel: 
Distributions of regional MS strength in HC at a range of connection densities (10%‒
90% in 10% increments). Right panel: Tabulated Pearson’s correlation between mean 
MS values between non-thresholded MSNs and connection densities across parcels 
(10%: adjusted pspin = 0.00; 20%: adjusted pspin = 0.00; 30%: adjusted pspin = 0.00; 40%: 
adjusted pspin = 0.00; 50%: adjusted pspin = 0.00; 60%: adjusted pspin = 0.00; 70%: 
adjusted pspin = 0.00; 80%: adjusted pspin = 0.00; 90%: adjusted pspin = 0.00). All p values 
adjusted by FDR, and were determined based on one-sided tests. 
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4. Global case-control MSN differences 




Figure S4. Global mean and distributions of regional MSN. Left panel: Distributions 
of regional MSN strength, i.e., the averaged MSN of each region with all other regions, 
after regressing age, sex, and education for individuals with MDD (red) and HC (blue). 
Right panel: Box plots for global mean MS (after regressing age, sex, and education) in 
patients with MDD (n = 217) and HC (n = 208). Using Mann-Whitney test, there are no 
difference between individuals with MDD and HC (U = 21467, p = 0.38, uncorrected, 
two-sided test). Boxplots show the lower quartile (25th percentile), median, and 
upper quartile (75th percentile), respectively. The upper and lower whiskers denote 
the minimum and maximum, respectively. 
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5. Regional MSN differences in MDD relative to HC 
Seven brain regions showed statistically significant MS differences (all p < 0.05, FDR-
corrected) in MDD relative to HC. The brain region’ name, MNI coordinates, and 
statistic values of abnormal brain regions were listed in Table S2.  
 
Table S2. Regions showing abnormal MSN in individuals with MDD 
Region MNI coordinates (x, y, z) t-statistic p-value 
lh_isthmuscingulate_part2 -5.08 -42.79 28.46 3.36 0.0008 
lh_lateraloccipital_part7 -28.70 -89.41 2.44 4.09 0.00005 
lh_medialorbitofrontal_part2 -6.50 52.61 -11.10 3.33 0.0009 
lh_superiorfrontal_part5 -10.35 54.69 27.23 -4.03 0.00006 
rh_lateraloccipital_part1 18.65 -99.16 -7.39 3.29 0.001 
rh_lateraloccipital_part6 32.22 -84.39 8.26 3.32 0.0009 
rh_lateraloccipital_part8 29.43 -94.00 -5.36 4.10 0.00005 
Note: Table giving details for the seven statistically regions anatomical labels, 
coordinates (in fsaverage, MNI305 space), t-statistic values (obtained by two-sample 
t-tests using linear regression model), and p-values. All p-values survived after FDR 
correction with p < 0.05, and were determined based on two-sided tests. 
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6. Threshold selection effect on case-control MSN differences 
Although there was a minimal effect of threshold selection on MSN (validated in 
Supplemental Result 3), we also used additional connection densities (10%‒90% in 10% 
increments) to investigate the stability of case-control MSN differences. At all 
connection densities, we found that the patterns of case-control MSN differences 
were similar to the equivalent non-thresholded MSNs; Figure 2b (Pearson’s r values 
range from 0.270 to 0.999, all pspin < 0.0001, FDR-corrected; Figure S5). 
 
Figure S5. Replicable case-control MSN differences across connection densities. Left 
panel: Distributions of MDD-related changes in MSN at a range of connection densities 
(10%‒90% in 10% increments). Right panel: Tabulated Pearson’s correlation 
coefficients between case-control t-maps with non-thresholded MSNs and connection 
densities (10%‒90% in 10% increments) across parcels (10%: adjusted pspin = 0.00; 20%: 
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adjusted pspin = 0.00; 30%: adjusted pspin = 0.00; 40%: adjusted pspin = 0.00; 50%: 
adjusted pspin = 0.00; 60%: adjusted pspin = 0.00; 70%: adjusted pspin = 0.00; 80%: 
adjusted pspin = 0.00; 90%: adjusted pspin = 0.00). All p values were adjusted by FDR, 
and were determined based on one-sided tests. 
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7. TIV effect on case-control differences 
It is well-established that adjustment for total intracranial volume (TIV) can increase 
power in volumetric analyses4. Although there was no difference of TIV between MDD 
and HC (two-sided two-sample t-test, t(423) = 0.70, p = 0.49) in the discovery cohort, 
we also validated the TIV effect on our case-control differences by including TIV as a 
covariate in the LRM. We found that the pattern of case-control differences was 
similar with our case-control differences without including TIV as a covariate 
(Pearson’s r(306) = 0.997, pspin < 0.0001; Figure S6).  
 
 
Figure S6. Validation of TIV effect on case-control MSN differences. a Regional case-
control MSN differences after controlling for TIV in the discovery cohort. b Pearson’s 
correlation for 308 t-statistic regional values for case-control differences with and 
without controlling for TIV (Pearson’s r(306) = 0.997, pspin = 0.00). p value was 
determined based on a one-sided test. 
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8. Medication effect on case-control MSN differences 
To investigate the effects of medication on case-control MSN differences, we divided 
the individuals with MDD into two subgroups: drug-experienced (n = 102) and drug-
naïve (n = 107), where eight patients were without medication information and were 
thus excluded. For each group, we obtained two case-control MSN t-maps, drug-
experienced vs. HC, and drug-naïve vs. HC, both of which showed similar case-control 
differences with the original combined group of individuals with MDD; Figure 2b (drug-
experienced subgroup: Pearson’s r(306) = 0.90, pspin < 0.0001, FDR-corrected; drug-
naïve subgroup: Pearson’s r(306) = 0.89, pspin < 0.0001, FDR-corrected; Figure S7).  
 
Figure S7. Medication effect on case-control MSN differences. a Regional t-map of 
drug-experienced group compared to HC in the discovery cohort. b Pearson’s 
correlation for the 308 t-statistic values obtained from the drug-experienced vs. HC 
and MDD patients vs. HC. comparisons (Pearson’s r(306) = 0.90, adjusted pspin = 0.00, 
FDR-corrected). p value was determined based on a one-sided test. c Regional t-map 
of drug-naive compared to HC in the discovery cohort. d Pearson’s correlation for the 
308 t-statistic values obtained from drug-naive vs. HC groups and MDD patients vs. HC 
comparisons (Pearson’s r(306) = 0.89, adjusted pspin = 0.00, FDR-corrected). p value was 
determined based on a one-sided test. 
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9. Yeo functional networks and von Economo classes 
To contextualize the regional MSN differences, we divided the all 308 cortical regions 
into two prior parcellation networks: Yeo 7 functional networks (Figure S8a) based on 
resting-state networks derived from functional MRI5, and the von Economo classes of 
cortex (Figure S8b) classified by cytoarchitectonic criteria6. To perform this analysis, 
we calculated the t-statistics and corresponding p values for each network-related 
change in MSN within a particular Yeo 7 networks (Table S3) and von Economo class 
(Table S4). We found that individuals with MDD exhibited increased MSN in Yeo visual 
functional networks (pFDR = 0.007) (Figure S8c). MSN was also increased in von 
Economo secondary sensory classes (pFDR = 0.02) (Figure S8d).  
 
Table S3. t-statistics and p-values for regional MSN differences across each Yeo 
network. 




Limbic Frontoparietal Default 
mode 
t-statistic 3.290 -0.495 -0.575 -1.135 -0.711 -0.427 -2.008 
p-value 0.001 0.621 0.565 0.257 0.478 0.670 0.048 
Note: The abnormal networks were shown in bold font (Visual: pFDR = 0.007) after FDR-
corrected with p < 0.05. t-statistic values were obtained by two-sample t-tests. All p 
values were determined based on two-sided tests. 
 









t-statistic -1.815 -2.058 -1.231 3.408 1.186 1.431 0.139 
p-value 0.070 0.044 0.219 0.003 0.236 0.153 0.889 
Note: The abnormal classes were shown in bold font (Secondary sensory: pFDR = 0.02) 
after FDR-corrected with p < 0.05. t-statistic values were obtained by two-sample t-
tests. All p values were determined based on two-sided tests. 
 




Figure S8. Yeo functional networks and von Economo classes of case-control 
differences in regional MSN. a The Yeo 7 functional networks. b The von Economo 
classes. c The distribution of case-control differences in Yeo-visual network (two-
sample t-test: t(420) = 3.24, p = 0.001, two-sided test, FDR-corrected pFDR = 0.007) 
between MDD (n = 217) and HC (n = 208) groups. d The distribution of case-control 
differences in von Economo classes-secondary sensory (two-sample t-test: t(420) = 3.24, 
p = 0.003, two-sided test, FDR-corrected pFDR = 0.02) between MDD (n = 217) and HC 
(n = 208) groups. Boxplots show the lower quartile (25th percentile), median, and 
upper quartile (75th percentile), respectively. The upper and lower whiskers denote 
the minimum and maximum, respectively. 
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10. MSN values-clinical associations in individuals with MDD 
We investigated the relationship between the regional MSN differences and clinical 
measures including 17-item Hamilton Depression Rating Scale (HAMD) and Hamilton 
Anxiety Rating Scale (HAMA). For each patient, we extracted the MS values in the 7 
regions where MSN increased/decreased significantly in individuals with MDD 
compared to HC. The results of a Pearson’s correlation between clinical measures and 
regional MSN values in the 7 regions are shown in Table S5. FDR correction was used 
to assess multiple comparisons. 
 
We observed a positive correlation between MSN values of the right lateral occipital 
(part 8) and the HAMD scores (Pearson’s r(215) = 0.135, p = 0.046), which did not survive 
after FDR correction. This positive correlation meant that individuals with MDD with 
more severe HAMD scores tended to have higher degree of increased regional MSN 
differences compared to HC. The opposite direction was observed between MSN 
values of the left superior frontal (part5) and the HAMD scores (Pearson’s r(215) = -
0.117, p = 0.086). There were no significant correlations between MSN values of 
significantly increased/decreased regions and the HAMA scores. 
 
We also explored the relationship between MSN values and HAMD and HAMA scores 
at whole-brain level. As an exploratory analysis, we did not correct the p-values in 
correlation analysis. We found that the left DLPFC exhibited negative correlation with 
HAMD scores (Pearson’s r values range from -0.14 to -0.22), whereas occipital cortices, 
middle/posterior cingulate cortex, and precentral cortex showed positive correlation 
with HAMD scores (Pearson’s r values range from 0.14 to 0.20, Figure S9a). For HAMA 
scores, right DLPFC showed negative correlations (Pearson’s r values range from -0.14 
to -0.21), whereas left visual cortex and right temporal cortex exhibited positive 
correlations (r values range from 0.14 to 0.16, Figure S9b).
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Table S5. The relationship between MSN values of abnormal regions and the HAMD 
and HAMA scores.  
 Brain regions HAMD HAMA 
r p r p 
Increased MSN isthmuscingulate (part2, L) 0.129 0.059 -0.004 0.953 
lateraloccipital (part7, L) 0.087 0.204 -0.012 0.861 
medialorbitofrontal (part2, L) 0.017 0.802 0.085 0.215 
lateraloccipital (part1, R) 0.105 0.122 0.037 0.592 
lateraloccipital (part6, R) 0.121 0.074 0.050 0.459 
lateraloccipital (part8, R) 0.135 0.048 0.042 0.534 
Decreased MSN superiorfrontal (part5, L) -0.117 0.086 -0.002 0.981 
Note: All r values were obtained by Pearson’s correlation analysis. All p values were 
not survived after FDR-corrected, and were determined based on two-sided tests. 
 
 
Figure S9. Correlation analysis between MSN values and clinical measures at whole-
brain level. a MSN values related to HAMD scores. b MSN values related to HAMA 
scores. 
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11. Transcriptome analysis 
11.1 Gene expression of AHBA atlas 
We used the AHBA atlas (http://human.brain-map.org)—a whole-genome, whole-
brain transcriptomic dataset to obtain brain gene expression. The AHBA dataset 
includes six neurotypical adult brains, three Caucasian, two African-American and on 
Hispanic. Their ages range from 24 to 57 years (age = 42.5 ± 13.38 years; male/female 
= 5/1). The detailed information was shown in Table S6.  
 
Table S6. Demographics of six adult donors in AHBA dataset 
 
Donor Number of 
cohorts 
Age Sex Ethnicity Post-mortem 
interval a 
H0351.2001b 946 24 Male African 
American 
23h 
H0351.2002b 893 39 Male African 
American 
10h 
H0351.1009 363 57 Male Caucasian 25.5h 
H0351.1012 529 31 Male Caucasian 17.5h 
H0351.1015 470 49 Female Hispanic 30h 
H0351.1016 501 55 male Caucasian 18h 
Note: 
a Post-mortem interval is defined as the time period from the time of death to the 
time the tissue is frozen. 
b These donors have tissue cohorts collected across the left and right hemispheres, 
while the other donors have tissue cohorts only in the left hemisphere. 
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11.2 Estimation of regional gene expression 
We followed Arnatkevic et al.7 to obtain brain gene expression: i) verifying probe-to-
gene annotations. Probe-to-gene annotations were provided by Arnatkevic et al.7 
using Re-annotator toolkit8. After the reannotation, a final set of 45,812 probes were 
uniquely annotated to a gene and could be related to an entrez ID. Sequent analysis 
used the re-annotated set of 45,821 probes, corresponding to 20,232 unique genes; 
ii) filtering of probes that do not exceed background noise. To improve the validity of 
microarray expression measures, intensity-based filtering was used9-11. Here, probes 
that do not exceed the background in at least 50% of all cohorts across all subjects 
were excluded; iii) probe selection. Generally, multiple probes can be used to measure 
the expression level of a single gene at different exons, in these cases, probe with the 
highest correlation to RNA-seq data is selected12; iv) cohort assignment. To assign 
cohorts to brain regions more accurately, T1w of six donors’ brains were firstly 
preprocessed using FreeSurfer. The D-K 308 atlas (152 regions in left hemisphere, and 
156 regions in right hemisphere) employed in the neuroimaging dataset was 
reconstructed in each AHBA donor brain. Then a threshold was applied to avoid 
assigning cohorts beyond a certain distance13, i.e., cohorts located less than 2 mm 
(Euclidean distance) to a region boundary were included; v) normalization of 
expression measures to account for inter-individual differences and outlying values. 
Gene expression data were normalized using the scaled robust sigmoid14, 15 for each 
subject to eliminate the inter-individual differences in expression measures; vi) gene-
set filtering. With the absence of a specific hypothesis, we selected genes based on 
differential stability to reduce donor-specific variance and focused on brain-relevant 
genes. Finally, the mean of all cohorts in a region was calculated to summarize the 
expression vector, resulting in a region × gene matrix of size 308 × 10,027. Because of 
AHBA dataset only includes two subjects with right hemisphere, we only considered 
gene expression in left hemisphere in our analysis, i.e., the region × gene matrix of size 
was 152 × 10,027. 
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11.3 Enrichment pathways from significantly positively weighted genes 
As reported in the main test, there were 1,747 genes with Z > 5. The enrichment 
pathways of PLS+ genes were shown in Figure S10. The PLS1+ genes were enriched for 
GO biological processes, such as “signal release”, and “synaptic vesicle priming”, but 
no KEGG pathways. All these pathways were corrected by FDR, with p value shown in 




Figure S10. Enrichments pathways of positively weighted genes with Z > 5. 
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Table S7. GO Biological Process enrichments from the PLS+ gene set (Z > 5). 
 
Category Z-score GeneInGOAndHitList -log10(q-value) 
GO: signal release 4.945 61 2.234 
GO: organelle localization 5.12 88 2.617 
GO: synaptic vesicle priming 5.675 8 1.743 
GO: protein-containing complex 
localization 
4.849 42 2.024 
GO: plasma membrane bounded 
cell projection assembly 
5.562 77 2.936 
GO: microtubule-based process 4.287 87 1.752 
GO: protein localization to cilium 5.075 14 1.752 
GO: intracellular receptor 
signaling pathway 
5.256 43 2.438 
GO: circadian regulation of gene 
expression 
4.957 15 1.706 
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11.4 Multi-gene-list meta-analysis between MS differences-related genes and genes 
from GWAS 
We compiled data from two recent GWAS studies which provided genes that were 
significantly associated to the MDD phenotype16, 17. To specify the gene ranks obtained 
by the PLS method, we performed a multi-gene-list meta-analysis between PLS1- gene 
list and genes list from GWAS studies. Figure S11 showed the unique and overlapped 
enrichment pathways. The six overlapped same enrichment pathways between the 
two gene lists included “cognition”, “Ras protein signal transduction”, “regulation of 
ion transport”, “synaptic signaling”, “synapse organization”, and “cell-cell adhesion via 
plasma-membrane adhesion molecules”.  
 




Figure S11. Overlapped ontology terms between discovery cohort and GWAS studies. 
(A) Enrichment heatmap visualization. The heatmap cells are colored by their p-values, 
white cells indicate the lack of enrichment for that term in the corresponding gene list. 
(B) Left panel was a subset of ontology terms. Right panel was the overlapped 
distribution. The same enrichment network has its nodes displayed as pies. Each pier 
sector is proportional to the number of hits originated from a gene list. Red is for 
discovery cohort, and blue is for GWAS studies. 
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12. Validation analysis in replication cohort 
12.1 Reproducibility of MDD-related MS differences 
Figure S12a showed the regional patient/control MSN t-statistics (after regressing out 
age, sex, and education levels) from replication cohort, with decreased frontal and 
temporal cortices and increased occipital cortex in MDD compared to HC. To observe 
the replicable MS differences, we performed the Pearson’s correlation analysis for t-
statistic values between discovery and replication cohorts (Figure S12b, Pearson’s r(306) 
= 0.43, pspin < 0.0001, this permutation testing based on spin of the spatially correlated 
MSN map) across regions. To validate not all t -maps of MSN differences might yield 
similar sized correlations, we performed an additional sensitivity analysis between 
case-control MSN t-map in discovery cohort and other conditions. Considering the 
common psychiatric and neurological disorders, we included a cross-sectional 
characterization of the MSN distribution of schizophrenia provided by a previous study 
(published online)2, t-maps of epilepsy vs. control differences (our unpublished data), 
and male vs. females amongst HC participants in this study Together they represent, 
to our knowledge, the currently available MSN measurements. No significant 
correlations were found in these additional analyses (Figure S12c). In addition, the 
correlation of t-maps between discovery and replication cohorts was substantially 
higher than the correlation of t-maps between discovery cohort of MDD and 
schizophrenia vs. HC in Cobre center (Steiger’s z value = 3.10, p = 0.002), epilepsy 
(Steiger’s z value = 3.34, p = 0.0008) vs. HC and male vs. female (Steiger’s z value = 
3.94, p = 0.0001). These statistical comparisons of correlations were conducted in 
http://comparingcorrelations.org/18.  
 




Figure S12. Replicable regional MSN differences of MDD. a Regional case-control MS 
differences in replication cohort. b Pearson’s correlation analysis for 308 t-statistic 
values between discovery and replication cohorts (Pearson’s r(306) = 0.43, pspin = 
0.0002). c Additional analyses for correlation of t-maps between discovery cohort and 
schizophrenia cohort (Pearson’s r(306) = 0.26, pspin = 0.09), epilepsy cohort (Pearson’s 
r(306) = 0.19, pspin = 0.06), and male vs. female (Pearson’s r(306) = 0.10, pspin = 0.17). All p 
values were not further corrected by multiple comparisons, and were determined 
based on one-sided tests. 
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12.2 Uncorrected overlapped ontology terms in reproducibility of MDD-related 
transcriptomic analysis 
To our knowledge, this is the first study to explore the generalized ontology terms of 
regional MSN differences in individuals with MDD. Thus, Figure S13 showed the 
uncorrected overlapped ontology terms between discovery and replication cohorts 
for better visualization. 
 
 
Figure S13. Uncorrected overlapped ontology terms between discovery and 
replication cohorts. a The name of overlapped ontology terms. b The same 
enrichment network has its nodes displayed as pies. Each pier sector is proportional 
to the number of hits originated from a gene list. Red is for discovery cohort, and blue 
is for replication cohort. 
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